Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populations. (Q45385615)
Jump to navigation
Jump to search
scientific article published in April 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populations. |
scientific article published in April 2009 |
Statements
Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populations (English)
Leonard E Weisman